OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clonal hematopoiesis associated with epigenetic aging and clinical outcomes
Daniel Nachun, Ake T. Lu, Alexander G. Bick, et al.
Aging Cell (2021) Vol. 20, Iss. 6
Open Access | Times Cited: 97

Showing 51-75 of 97 citing articles:

Ageing and cancer: a research gap to fill
Éric Solary, Nancy Abou-Zeid, Fabien Calvo
Molecular Oncology (2022) Vol. 16, Iss. 18, pp. 3220-3237
Open Access | Times Cited: 12

Clonal hematopoiesis of indeterminate potential and cardiovascular disease
Seyedmohammad Saadatagah, Christie M. Ballantyne
Translational research (2022) Vol. 255, pp. 152-158
Closed Access | Times Cited: 12

Impact of Clonal Hematopoiesis–Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial
Julieta Rodriguez, Capucine Baldini, Arnaud Bayle, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 2

Clonal Hematopoiesis of Indeterminate Potential and Long-term Outcomes in Heart Transplantation
Panagiotis Simitsis, Anju Nohria, J Kelleher, et al.
Journal of Cardiac Failure (2024)
Closed Access | Times Cited: 2

Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions
Saivaroon Gajagowni, Steven P. Hopkins, Yusuf Qadeer, et al.
Progress in Cardiovascular Diseases (2024)
Closed Access | Times Cited: 2

The emergence of clonal hematopoiesis as a disease determinant
Kenneth Walsh
Journal of Clinical Investigation (2024) Vol. 134, Iss. 19
Open Access | Times Cited: 2

CHIPing away the progression potential of CHIP: A new reality in the making
Zhuoer Xie, Amer M. Zeidan
Blood Reviews (2022) Vol. 58, pp. 101001-101001
Open Access | Times Cited: 11

Therapy-Related Clonal Hematopoiesis
Yoshimitsu Yura, Jesse D. Cochran, Kenneth Walsh
Heart Failure Clinics (2022) Vol. 18, Iss. 3, pp. 349-359
Open Access | Times Cited: 10

Time to relapse in chronic lymphocytic leukemia and DNA-methylation-based biological age
Drew Nannini, Rene Cortese, Peter Egwom, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 6

Germline genomic and phenomic landscape of clonal hematopoiesis in 323,112 individuals
Md Mesbah Uddin, Zhi Yu, Joshua S. Weinstock, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 9

Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy
Jiarna R. Zerella, Claire C. Homan, Peer Arts, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4

Whole exome sequencing analyses reveal novel genes in telomere length and their biomedical implications
Weishi Liu, Bang‐Sheng Wu, Yang Liu, et al.
GeroScience (2024) Vol. 46, Iss. 5, pp. 5365-5385
Open Access | Times Cited: 1

Decoding Clonal Hematopoiesis: Emerging Themes and Novel Mechanistic Insights
Shalmali Pendse, Dirk Loeffler
Cancers (2024) Vol. 16, Iss. 15, pp. 2634-2634
Open Access | Times Cited: 1

Clonal hematopoiesis in cardiovascular aging: Insights from the verona heart study
Katarzyna Malgorzata Kwiatkowska, Nicola Martinelli, Luca Bertamini, et al.
GeroScience (2024)
Closed Access | Times Cited: 1

Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins
Mette Soerensen, Morten Tulstrup, Jakob Werner Hansen, et al.
HemaSphere (2022) Vol. 6, Iss. 9, pp. e768-e768
Open Access | Times Cited: 7

Emerging evidence on the role of clonal hematopoiesis of indeterminate potential in chronic kidney disease
Zhijie Huang, Caitlyn Vlasschaert, Cassianne Robinson‐Cohen, et al.
Translational research (2022) Vol. 256, pp. 87-94
Open Access | Times Cited: 7

Advances in understanding the molecular basis of clonal hematopoiesis
David A. Alagpulinsa, Mabel Toribio, Iad Alhallak, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 5, pp. 360-377
Closed Access | Times Cited: 6

Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome
Miriam Díez-Díez, Marta Amorós-Pérez, Jorge de la Barrera, et al.
GeroScience (2022) Vol. 45, Iss. 2, pp. 1231-1236
Open Access | Times Cited: 6

Human Plasma Proteomic Profile of Clonal Hematopoiesis
Zhi Yu, Amélie Vromman, Ngoc Quynh Nguyen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3

Molecular Studies for the Early Detection of Philadelphia-Negative Myeloproliferative Neoplasms
Ruth Stuckey, Cristina Bilbao, Adrián Segura-Díaz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12700-12700
Open Access | Times Cited: 3

Epigenetic roles in clonal hematopoiesis and aging kidney-related chronic kidney disease
Yoshiyasu Ogura, Imari Mimura
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 3

Somatic mutation as an explanation for epigenetic aging
Zane Koch, Adam Li, Daniel S. Evans, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3

Epigenetic Mechanisms in Hematologic Aging and Premalignant Conditions
Bowen Yan, Qingchen Yuan, Olga A. Guryanova
Epigenomes (2023) Vol. 7, Iss. 4, pp. 32-32
Open Access | Times Cited: 3

Scroll to top